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Abstract
Background: The winter pressure often experienced by NHS hospitals in England is considerably contributed to by
severe cases of seasonal influenza resulting in hospitalisation. The prevention planning and commissioning of the
influenza vaccination programme in the UK does not always involve those who control the hospital budget. The
objective of this study was to describe the direct medical costs of secondary care influenza-related hospital
admissions across different age groups in England during two consecutive influenza seasons.
Methods: The number of hospital admissions, length of stay, and associated costs were quantified as well as determining
the primary costs of influenza-related hospitalisations. Data were extracted from the Hospital Episode Statistics (HES)
database between September 2017 to March 2018 and September 2018 to March 2019 in order to incorporate the annual
influenza seasons. The use of international classification of disease (ICD)-10 codes were used to identify relevant influenza
hospitalisations. Healthcare Resource Group (HRG) codes were used to determine the costs of influenza-related
hospitalisations.
Results: During the 2017/18 and 2018/19 seasons there were 46,215 and 39,670 influenza-related hospital admissions
respectively. This resulted in a hospital cost of £128,153,810 and £99,565,310 across both seasons. Results showed that
those in the 65+ year group were associated with the highest hospitalisation costs and proportion of in-hospital deaths. In
both influenza seasons, the HRG code WJ06 (Sepsis without Interventions) was found to be associated with the longest
average length of stay and cost per admission, whereas PD14 (Paediatric Lower Respiratory Tract Disorders without Acute
Bronchiolitis) had the shortest length of stay.
Conclusion: This study has shown that influenza-related hospital admissions had a considerable impact on the secondary
healthcare system during the 2017/18 and 2018/19 influenza seasons, before taking into account its impact on primary
health care.
Keywords: Influenza, Burden of illness, Hospitalisation, Secondary healthcare, Vaccination, HES, Hospital episode statistics,
Immunisation
Background
Seasonal influenza disease epidemics contribute consider-
ably to winter pressures in the UK with severe cases result-
ing in hospitalisation due to complications. There is
inadequate immunity from season to season associated with
limited capacity of the influenza vaccine due to the genetic
drift of the virus, which results in regular changes in the cir-
culating strains [1, 2]. The lack of immunity from season to
season stresses the need for regular re-assessment of the
impact of influenza. Annual influenza epidemics are associ-
ated with approximately 290,200 to 645,800 respiratory
deaths a year worldwide [3]. In the UK during the 2017–18
flu season, moderate to high levels of influenza activity were
observed with co-circulation of influenza B and influenza A
(H3) [4]. There were 15,969 excess deaths associated with
influenza in the UK as estimated by the FluMOMO model
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of influenza [4]. However, laboratory confirmed influenza
was associated with a total of 3175 admissions to intensive
care unit/high dependency unit in England [4]. A 2016
study by Matias et al. [5] estimated the burden of influ-
enza in the UK using weekly hospital admission and death
data in combination with Public Health England’s virology
reports on influenza and respiratory syncytial virus. The
authors found considerable seasonal burden of illness
across all age groups. Evidence suggests prevention and
early intervention may be effective mechanisms for redu-
cing the burden of influenza.
Prior to 2012, the UK vaccination policy covered groups
at higher risk of severe outcomes, pregnant women, and all
those aged 65 years and over [5]. However, the programme
was extended in 2012 to include all children between the
ages of 2 and 17 years following a recommendation by the
Joint Committee on Vaccination and Immunisation (JCVI)
in order to further reduce the burden and spread of influ-
enza [6]. During the 2018 to 2019 influenza season in Eng-
land, those aged 65 years and older had a vaccine uptake
rate of 72.0%, whereas 48.0% of those aged 6months to
under 65 years in an at-risk group were vaccinated [7]. The
lower vaccine uptake rate in those under the age of 65, and
the consequence of that on secondary care resource avail-
ability for all ages, emphasises the need to assess the direct
medical costs of seasonal influenza across all age groups.
Although the influenza vaccination programme in the UK
is well established, those who control the hospital budget are
not always involved in the prevention planning or commis-
sioning of the programme. A recent systematic review of 27
cost of illness studies, including one from the UK, investi-
gated the effects of influenza-related direct health care costs
with a specific focus on inpatient and outpatient costs [8].
The review found that inpatient and outpatient services
accounted for 43.5 and 44.5% of the total cost per episode.
The study noted that global differences in the cost per influ-
enza episode (US$19 in Korea to US$323 in Germany) may
be affected by country specific characteristics [8]. The find-
ings also highlighted that children are associated with higher
costs, whereas evidence for the elderly is less conclusive.
However, the study did not focus on the costs of severe in-
fluenza cases that specifically resulted in hospitalisation.
Therefore, there is a need to estimate the burden of influ-
enza on secondary healthcare. Additionally, the cost by age
group needs to be considered to improve our understanding
of the burden of influenza among the different age groups to
support discussion around vaccination policies.
The objective of this paper is to describe the direct
medical costs of secondary care influenza-related admis-
sions across different age groups in England during the
2017/2018 and 2018/2019 influenza seasons in two ways.
First, quantify the influenza-related hospital admissions,
length of stay, and associated costs. Second, describe the
principle costs for hospital admissions due to influenza.
The costing perspective covered all mild or severe influ-
enza admissions to secondary care including those trans-
ferred to intensive care units.
Methods
Data sources
Data were extracted from the Hospital Episode Statistics
(HES) database for two annual influenza seasons. The data
ranged from September 2017 to March 2018 and Septem-
ber 2018 to March 2019 in order to incorporate the an-
nual influenza seasons. The seasonal influenza data were
stratified by the following age groups: < 65, 65–74 and
75+ years in order to assess the burden of illness in both
the under 65 s and the elderly. All non-elective hospital
admissions, patient counts, bed days, tariff costs, and
deaths were determined using international classification
of disease (ICD)-10 codes. Individuals were included
within the analysis if they had a primary or secondary
ICD-10 code specifically related to influenza in any diag-
nosis field (J09–11; Table 1). However, it was not possible
to extract information regarding the vaccination status for
this population from the HES database. Furthermore, the
number and type of comorbidities for these individuals
was not assessed during this study. The inclusion and ex-
clusion criteria of the study are summarised in Table 2.
Within the HES database, age is recorded in 5 year age
bands based upon the recorded date of birth of the se-
lected patients. This enabled patients to be categorised
into age groups closely linked to those outlined in the UK
vaccination recommendations. In order to maintain pa-
tient confidentiality, a method known as small number
suppression was utilised in accordance with NHS Digital
guidelines. This method involves rounding patient num-
bers to the nearest five to reduce the risk of individuals in
small groups being identified from other published
sources. The national mean length of stay was calculated
from the extracted data. As the provided HES data were at
an aggregated cohort level rather than at an individual pa-
tient level, it was not possible to use the median length of
stay per influenza-related hospitalisation. The proportion
of patients dying in hospital was estimated from those re-
corded as having a method of hospital discharge as “Died”.
Costs
Hospitalisation costs were determined by using the patient’s
ICD-10 codes. ICD-10 codes are not directly associated
Table 1 ICD-10 codes used to define influenza
ICD-10 code Definition
J09 Influenza due to certain identified influenza viruses
J10 Influenza due to other identified influenza virus
J11 Influenza due to unidentified influenza virus
ICD International classification of disease
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with a cost, therefore these codes are linked to a corre-
sponding Healthcare Resource Group (HRG) code. NHS
England uses HRG codes to group patient events that have
been deemed to use a similar amount of healthcare re-
sources together. HRG codes are used as tariff payments
for each hospital admission or procedure. This study used
the five most common HRG codes associated with the
ICD-10 codes listed in Table 1 to identify the costs of non-
elective influenza hospitalisations.
Software
All analyses were performed in Microsoft Excel® (Micro-
soft, Redmond, Washington DC, USA).
Results
Influenza-related hospitalisations
In the 2017/18 influenza season, 46,215 influenza-related
hospital admissions were recorded for 41,730 individual
patients in England. This fell to 39,670 influenza-related
hospital admissions for 35,415 patients in the 2018/2019
influenza season. This equates to 1.11 and 1.12
influenza-related hospitalisations per patient in the
2017/18 and 2018/19 influenza seasons respectively. The
number of influenza-related admissions resulted in a total
of 401,145 of bed days and a hospital cost of £128,153,810
with an average length of stay (LoS) of 8.68 days at an
average cost of £2773 per admission in the 2017/18 sea-
son. In comparison, the 2018/19 influenza season was as-
sociated with fewer bed days (286,256) and consequently a
reduced hospital cost of £99,565,310. This decrease in
total number of bed days and hospital costs was expected
following the reduction in the number of admissions.
The average LoS for patients in the 2018/19 influenza
season was 7.22 days at an average cost of £2510 per
admission. The number of patients dying in hospital
fell from 6.81% in the 2017/18 influenza season to
5.12% in the 2018/19 season.
Influenza-related hospitalisations by HRG code
During the September 2017 to March 2018 and Septem-
ber 2018 to March 2019 influenza seasons, the top five
HRG codes by influenza-related hospital admission were:
WJ03 (Standard Infectious Diseases without Interven-
tions), DZ11 (Lobar, Atypical or Viral Pneumonia, without
Interventions), PD14 (Paediatric Lower Respiratory Tract
Disorders without Acute Bronchiolitis), WJ06 (Sepsis
without Interventions) and DZ65 (Chronic obstructive
Pulmonary Disease or Bronchitis, without Interventions).
Table 3 summarises the total admissions, total number of
bed days and the total costs associated with each of the
top five HRG codes in both influenza seasons.
During the 2017/18 influenza season, HRG code WJ03
resulted in the largest number of influenza-related hos-
pital admissions. However, the code was also associated
with the cheapest cost per admission (~£1600) and an
average LoS of 4.2 days per admission. The HRG code
with the largest average LoS per admission was WJ06 at
12.9 days, approximately 28% longer than the next lar-
gest LoS (9.8 days) for DZ11 (Fig. 1). The average cost
per influenza-related hospital admission for WJ06 and
DZ11 was ~£4600 and ~ £3300 respectively. HRG code
DZ65 was associated with the third largest average LoS
at 8.5 days at an average cost of ~£2900 per admission.
The shortest average LoS per admission was 2.5 days for
PD14 at a cost of approximately £1700 per admission.
Similar trends were observed in the 2018/19 season,
HRG code WJ06 was associated with the largest average
LoS per admission at 12.9 days, approximately 44% higher
than the second largest stay per admission of 8.9 days for
DZ11. DZ65 was found to result in an average length of
stay per admission of 8.0 days, whereas the remaining two
HRG codes, WJ03 and PD14, have an average number of
LoS of 3.5 and 2.1 respectively. Furthermore, the average
LoS per admission was related to the average cost per
admission. WJ06 was associated with an average cost of
~£4600 per admission, while DZ11 had an average cost
of ~£3300 per admission. HRG codes DZ65, PD14 and
WJ03 were found to have an average cost per admission
of ~£2800, ~£1600 and ~ £1400 respectively.
Influenza-related hospitalisations by age group
Further analysis of the September 2017 to March 2018 in-
fluenza season revealed that the average LoS and cost per
influenza-related admission were highest in the 75+ year
age group (12.55 days and ~ £3500), followed by the 65–
74 year age group (9.08 days and ~ £3000). Those in the
< 65 year age group were associated with an average
length of stay of 5.01 days per admission with an average
cost of ~£2000. The proportion of patients dying in hospital
was found to increase with age, rising from 2.16% in the
under 65 age group to 11.02% in the 75+ year age group.
Similar breakdown of the September 2018 to March
2019 influenza season found comparable trends to those
observed in the previous season. The average LoS and cost
per influenza-related admission was associated with age
group, falling from 12.55 days and approximately £3700
per admission in the 75+ year age group to 4.74 days with
an average cost of approximately £1900 per admission in
Table 2 Inclusion and exclusion criteria
Inclusion Exclusion
Non-elective admissions None
ICD-10 codes: J09–11 as a primary
or secondary diagnosis
All age groups
Date range: September 2017 –
March 2018 and September
2018 – March 2019
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the < 65 year age group. Those in the 65–74 year age
group were found to have an average LoS of 9.04 days and
an average influenza-related hospital admission cost of
~£3100. As in the previous influenza season, the propor-
tion of patients dying in hospital was found to increase with
age. The proportion of in-hospital deaths, rose from 1.83%
in the under 65 age group to 11.18% in the 75+ year age
group. The findings for both influenza seasons are sum-
marised in Table 4.
Overall, the 65+ year age group accounted for 57% of
all influenza-related admissions, 75% of inpatient bed
days and 69% of hospital costs in England during the
2017/18 season. In contrast, during the 2018/19 influ-
enza season, the 65+ year age group only accounted for
38% of all influenza-related admissions, 59% of inpatient
bed days and 53% of hospital costs (Fig. 2).
In the 2017/18 influenza season, the HRG code WJ06 was
associated with the highest LoS and cost per admission in
Table 3 Top five HRG codes associated with influenza during the 2017/2018 and 2018/19 seasons
HRG
Code
2017/18 influenza season 2018/19 influenza season
Total Admissions Total Bed Days Total Cost (£) Total Admissions Total Bed Days Total Cost (£)
DZ11 10,865 106,905 35,753,131 8690 77,455 28,845,144
DZ65 1281 10,905 3,721,948 873 7010 2,464,886
PD14 2330 5835 3,876,050 4395 9220 6,857,201
WJ03 15,740 65,610 24,417,723 13,875 48,200 19,585,195
WJ06 2452 30,830 10,848,700 1166 14,992 5,410,835
DZ11 Lobar, atypical or viral pneumonia, without interventions, DZ65 Chronic obstructive pulmonary disease or bronchitis, without interventions, PD14 Paediatric
lower respiratory tract disorders without acute bronchiolitis, WJ03 Standard infectious diseases without interventions, WJ06 Sepsis without interventions
Fig. 1 Average cost and length of stay for each admission during the 2017/18 and 2018/19 influenza seasons. The columns represent the
average cost per admission, whereas the black dots indicate the average length of stay per admission for each of the top five HRG codes. The
results indicate a similar trend was observed over both the September 2017 to March 2018 and the September 2018 to March 2019 influenza
seasons. DZ11, Lobar, Atypical or Viral Pneumonia, without Interventions; DZ65, Chronic obstructive Pulmonary Disease or Bronchitis, without
Interventions; PD14, Paediatric Lower Respiratory Tract Disorders without Acute Bronchiolitis; WJ03; Standard Infectious Diseases without
Interventions; WJ06, Sepsis without Interventions
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the > 65 year age group at 14.1 days and ~ £4700 respect-
ively. The same was observed in the 2018/19 season which
found that WJ06 resulted in an average LoS of 14.9 days at
an average cost of approximately £4900 per admission. Out
of the top five HRG codes, PD14 contributed to 17% of the
total costs in the under 65 year age group during the 2017/
18 season. This rose slightly to 20% in the 2018/19 season.
The longest LoS and cost per admission in the under 65
year group during the 2017/18 season was WJ06 with an
average LoS of 8.9 days and an average cost of ~£3800. Dur-
ing the 2018/19 season, WJ06 was still associated with the
longest average LoS and cost per admission in the under 65
year group. However, the average LoS and cost per admis-
sion had risen to 10.1 days and ~ £4300 respectively.
Discussion
During both the September 2017 to March 2018 and
September 2018 to March 2019 influenza seasons, there
were a high number of influenza-related hospital admis-
sions. This resulted in a considerable cost to the health-
care system in terms of secondary care. There were 41,
730 and 39,670 influenza-related hospital admissions in
England during the 2017/18 and 2018/19 seasons re-
spectively. Both influenza seasons in this study show
similar trends and therefore may be considered to be
representative of the secondary care burden due to influ-
enza in England over the previous two influenza seasons.
This study was performed due to the lack of evidence
surrounding the impact of influenza on the secondary
healthcare burden in England. The study used influenza-
specific ICD-10 codes to identify all non-elective hospital
admissions, patient counts, bed days, tariff costs and
deaths. The HRG codes associated with the ICD-10 codes
were used to calculate a cost per influenza-related hospi-
talisation. These costs were then stratified by the top five
HRG codes and age group in order to determine the bur-
den of influenza on secondary healthcare by age group.
The study found that HRG codes related to respiratory
disease (Table 3), including pneumonia and lower respira-
tory tract infections collectively, were the largest contribu-
tors to total healthcare costs and influenza-related hospital
admission. HRG code WJ06 (sepsis without intervention)
resulted in the highest cost per admission and the longest
average LoS in both the 2017/18 and 2018/19 influenza sea-
sons. The average LoS, cost per admission and the propor-
tion of patients dying in hospital increased with age from
the under 65 year age group to the 75+ year age group.
Further revision of the current vaccination policy, for
those aged 65 years and over (the greatest burden of ill-
ness on secondary healthcare resources), may further re-
duce the pressures and the impact of hospitalisation often
facing the NHS during the winter period. This could lead
to cost savings for the healthcare system. However, in vul-
nerable groups such as the elderly and/or the terminally
ill, influenza may simply be a contributing cause of many
deaths rather than the sole cause [9–11]. Influenza is
known to aggravate a variety of respiratory conditions, in-
cluding chronic obstructive pulmonary disease (COPD)
and asthma, as well as increase the risk of myocardial in-
farction [12–16]. Furthermore, the influenza virus is no
longer detectable in most patients when complications
arise [11]. As a result, it is hard to determine the propor-
tion of these conditions that can be attributable to influ-
enza, especially in the elderly and/or the terminally ill
[11]. Therefore, it is not certain that reducing the burden
of influenza in these groups would lead to an improve-
ment in the average quality of life expectancy [9].
Previous burden of illness studies have investigated the
impact of influenza in the UK over multiple seasons by
assessing retrospectively collected longitudinal data [5,
17]. Cromer et al. [17] obtained data for the 8 years prior
to the A(H1N1)v pandemic in 2009 (April 2000 to
March 2008). The data was assessed using a generalised
linear model to determine trends over time within the
data. Cromer et al. found that 37% of all annual
influenza-related hospital admissions occurred in chil-
dren less than 15 years old. Furthermore, this group
made up 52% of all admissions amongst the non-risk
groups. This finding is broadly in line with our study
which found that those under the age of 65 contributed
to an average of 53% of all hospital admissions in the
2017/18 and 2018/19 season. However, we cannot make
a direct comparison as the age break down in our study
is not as granular. The study by Matias et al. [5]
Table 4 Influenza-related hospital outcomes by age group
Outcome Age groups
2017/18 influenza season 2018/19 influenza season
Under 65 65–74 75+ Under 65 65–74 75+
Number of patients 17,565 7320 16,060 21,570 4975 8495
Number of admissions 19,635 8140 17,650 24,335 5605 9350
Average length of stay (days) 5.01 9.08 12.55 4.74 9.04 12.55
Average cost per admission (£) 1989.57 3023.70 3506.06 1923.60 3103.75 3675.91
Proportion dying in hospital (%) 2.16 6.20 11.01 1.83 6.51 11.18
Moss et al. BMC Public Health         (2020) 20:1464 Page 5 of 8
modelled age-specific estimates of influenza-related hos-
pitalisations and mortality in the UK. The study col-
lected weekly data ranging from 1997 to 2009. Matias
et al. found that on average those aged 75+ years con-
tributed to 36% of all influenza-related hospitalisations.
This is directly comparable to our study which found
that 75+ year olds were responsible for 32% of all
influenza-related hospitalisations in the 2017/18 and
2018/19 seasons. Furthermore, this study observed that
75+ year olds were responsible for 49% of total bed days
across the two seasons, in line with previous findings by
Fleming et al. [18]. The results presented within this
study are in line with previous studies which have inves-
tigated the impact of influenza over multiple seasons.
Therefore, our findings may be considered representa-
tive of a typical influenza season.
Limitations
Estimating the burden of influenza-related hospital admis-
sions is often a challenge due to the diagnostic uncertainty
surrounding an accurate diagnosis of influenza as the
symptoms are non-specific. Patients who present with an
acute respiratory illness are not regularly assessed for
virological evidence of influenza infection nor is influenza
infection specified in routine databases such as hospital
discharge [17]. In addition, those with a relevant ICD-10
code recorded in the secondary position may actually have
hospital acquired influenza rather than influenza being the
cause of admission. This study cannot attribute influenza
as the sole cause of all disease burden presented due to
unmeasured confounders such as the number and type of
comorbidities for this population. This study was also un-
able to take into consideration the vaccination status of
those admitted for influenza as this is not recorded within
the HES database. Furthermore, the burden of influenza is
often under predicted as patients frequently present with
the complications of influenza rather than influenza itself.
Therefore, if influenza is never suspected or tested for in a
patient, their records would not be associated with an
ICD-10 code listed in Table 1.
The method used within this study did not account for
the number of patients who were discharged from hospital
but subsequently died. Therefore, the proportion of
influenza-related deaths may also be underestimated. The
small number suppression technique used within this
study to be compliant with NHS Digital guidelines may
Fig. 2 Influenza-related hospital outcomes by age group for the 2017/18 and 2018/19 influenza seasons. The proportion of patients contributing
to the number of hospital admissions, bed days and hospitalisation cost were stratified by age group across both influenza seasons. The results
indicate that the < 65 year age group in the 2018/19 influenza season contributed to a greater proportion of each of the three primary outcome
measures compared to the 2017/18 season
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have resulted in a marginal over representation of the total
number of influenza-related hospital admissions. Further-
more, as the LOS data were only available at a cohort level,
future studies could investigate the impact of influenza on
LOS at an individual patient level.
Influenza-related hospital admissions are associated with
a large number of HRG codes. However, only the top five
are presented in this paper. Future studies could group
HRG codes together for analyses to provide a broader indi-
cation of the associated tariffs as well as include the vaccin-
ation and comorbidity status of the population.
Conclusions
During the 2017/18 and 2018/19 influenza seasons,
influenza-related hospital admissions were a substantial
burden on the secondary healthcare system. The highest
cost and proportion of deaths were attributed to patients
age 65+ years. However, there was an increase in the pro-
portion of costs and influenza-related hospital admissions
attributable to the under 65 group during the 2018/19 sea-
son. Influenza can have a substantial impact on the health-
care system even before considering the wider impact on
primary healthcare and society as a whole. Future studies
assessing the burden of illness caused by influenza should
include the vaccination and comorbidity status of the
population to better understand the impact of these fac-
tors on the burden of illness. These studies will provide
the opportunity to assess whether revision of the influenza
vaccination programme may reduce winter pressures and
reduce the impact on hospitals from influenza.
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